ArticleBreast cancer research : BCR2026
Distinct genetic profiles of obesity have different effects on breast cancer risk: leveraging Mendelian randomisation to interrogate causal pathways and identify mediating proteins.
Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Adiposity and cancer: epidemiology, mechanisms and future perspectives.Nature metabolism · 2026Review
- Mendelian Randomization to Examine the Causal Effects of Cystatin on Ovarian Lesions.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a well-established risk factor for many cancers, but its association with breast cancer remains inconsistent. Obesity is a highly complex and polygenic condition, driven by multiple biological pathways, some of which have been linked to beneficial health effects, defining a metabolically healthy obese phenotype. We hypothesise that this heterogeneity may partly underlie the variable association with breast cancer, where different biological pathways may play divergent roles in disease risk.
methodsWe applied an approach in two parts to explore the heterogeneous effects of high body mass index (BMI) on breast cancer risk. First, we applied Mendelian randomisation (MR)-based clustering on genetic data (FinnGen, GIANT, BCAC) to identify clusters of BMI-increasing SNPs with differential effects on breast cancer, and the cluster-specific MR results were replicated in the UK Biobank. Second, we integrated proteomic data to estimate the cluster-specific effects of BMI on protein levels and the effect of these proteins on breast cancer risk, using two-sample MR. Mediation analyses were then carried out using the product-of-coefficient method.
resultsWe identified three clusters of SNPs associated with increased BMI while having differential effects on breast cancer risk: one risk-increasing (inverse variance weighted MR estimate: 1.27 [1.10, 1.44]), one medium protective (− 0.75 [− 0.82, − 0.68]), and one highly protective (− 1.92 [− 2.21, − 1.62]), comprising 24, 73, and 7 SNPs respectively, with similar magnitude of effects in the UK Biobank. In the two-sample MR, each cluster was associated with many proteins (70, 369 and 44 respectively, FDR q-value < 0.05), and the mediation analysis identified that three proteins significantly mediate cluster-specific effects on breast cancer risk. Among these proteins, MET is known to be involved in breast cancer, while little is known about the roles of CPM and CST6.
conclusionsThese findings suggest that the effect of obesity on breast cancer is mediated through multiple distinct biological pathways. The identified proteins provide a first insight into the mechanisms underlying these pathways. With further investigation, these results could provide a basis for developing personalised treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.